Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Avicanna Inc. (AVCNF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.23100.0000 (0.00%)
At close: 09:30AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2310
Open0.2310
BidN/A x N/A
AskN/A x N/A
Day's Range0.2310 - 0.2310
52 Week Range0.1170 - 0.7200
Volume2,000
Avg. Volume5,811
Market Cap17.186M
Beta (5Y Monthly)2.24
PE Ratio (TTM)N/A
EPS (TTM)-0.2570
Earnings DateJan 31, 2023 - Feb 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AVCNF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AVICANNA INC
    Analyst Report: EBay Inc.eBay Inc. provides online platforms, tools, and services to help individuals and merchants conduct online and mobile commerce in the United States and internationally. eBay completed the spinoff of its PayPal electronic payments service in July 2015, the sale of its StubHub business in February 2020, and the sale of its Classifieds business in June 2021.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • GlobeNewswire

    Avicanna Reports Q3 2022 Financial Statement

    TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, November 14, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-b

  • GlobeNewswire

    Avicanna Announces Closing of Non-Brokered Private Placement

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the development advancement, and commercialization of evidence-based, cannabinoid-based products, is

  • GlobeNewswire

    Avicanna Announces Extension of Term Loan

    TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid based products, announces that it has entered into a extension agreement (the “Extension Agreement”) in connection with its senior secured term loan previously announced on August 19, 2021 (the “Term Loan”). In accordance with the Extension Agreement,

Advertisement
Advertisement